Prima for geographic atrophy

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 5 Jan 2018: Trial registered, NCT03392324

The trials

NCT03392324: PRIMA US-Feasibility Study in Atrophic Dry AMD

State
Completed
Phase
No phase
People
5 taking part
Started
26 Apr 2018
Primary completion
20 May 2026
Arms
PRIMA
Results
None posted
  1. 5 Jan 2018: Trial registered
  2. 26 Apr 2018: Trial started
  3. 20 May 2026: Trial completed

How the status changed

  1. 19 Nov 2026: First set: Trial registered

About the treatment

Kind of treatment: Device.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.